Tower Research Capital LLC (Trc) Outset Medical, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Outset Medical, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 25,804 shares of OM stock, worth $15,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,804
Previous 13,445
91.92%
Holding current value
$15,740
Previous $29,000
241.38%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OM
# of Institutions
131Shares Held
39MCall Options Held
65.1KPut Options Held
91.3K-
Ameriprise Financial Inc Minneapolis, MN5.2MShares$3.17 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.82MShares$2.33 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.07MShares$1.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$1.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.94MShares$1.19 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $29.3M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...